ClinicalTrials.Veeva

Menu

Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.

J

Jun Li

Status and phase

Unknown
Phase 4

Conditions

Unstable Angina

Treatments

Drug: Anti-Platelet Drugs
Drug: Lipid Regulating Drugs
Drug: Coronary Vasodilator
Drug: Xuefu Zhuyu Decoction
Drug: Shuanghe Decoction
Drug: Gualou Xiebai Banxia Decoction & Danshen Decoction

Study type

Interventional

Funder types

Other

Identifiers

NCT03171597
YXFJ-2017

Details and patient eligibility

About

This study evaluates the clinical efficacy of the famous prescription in the treatment of unstable angina pectoris. All of the patients will be divided into 4 arms according to their syndrome type. One of the arms will be treated by conventional western medicine, the other three will be treated by different Chinese herbal medicine prescription at the base of conventional western medicine.

Full description

Xuefu Zhuyu Decoction has the function of activating qi and promoting blood circulation, which will be used to treat patients with qi stagnation and blood stasis syndrome.

GualouXiebaiBanxia Decoction compounded with Danshen Decoction has the effect of promoting blood circulation and resolving phlegm, so it will be used for patients taht belong to phlegm and blood stasis type.

Shuanghe Decoction has the function of supplementing Qi and activating blood circulation, which will be used to treat patients with Qi deficiency and blood stasis syndrome.

Enrollment

240 estimated patients

Sex

All

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants diagnosed with coronary heart disease through coronary angiography or coronary CTA;

Patients have at least one of these symptoms:

  1. The stability of the nature of angina pectoris changes, that is, frequent attacks of angina pectoris, serious degree and prolonged duration;
  2. Angina pectoris during rest;
  3. The recent occurrence of angina pectoris caused by mild physical activity in the last month.

Exclusion criteria

  • Patients dignosed with stable angina; Patients with acute myocardial infarction; Chest pain caused by congenital heart disease, valvular heart disease, severe neurosis or arrhythmia; The heart function grade is III or IV; Patients with acute cerebral infarction; Patients complicated with other serious primary diseases; Patients with acute infection in recent 2 weeks; Uncontrolled hypertension (the resting blood pressure >160/95mmHg within one week); Diabetics emerged with serious diabetic complications; Patients can't finish the questionnaire due to abnormal mental and nervous or mental disorders; Pregnant or lactating women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

240 participants in 4 patient groups

conventional western medicine
Other group
Description:
Patients in this group will be treated by conventional western medicine, including anti-platelet drugss,lipid regulating drugs, coronary vasodilator, etc.
Treatment:
Drug: Lipid Regulating Drugs
Drug: Anti-Platelet Drugs
Drug: Coronary Vasodilator
Qi deficiency and blood stasis
Experimental group
Description:
Patients in this group will be treated by Shuanghe Decoction at the base of conventional western medicine.
Treatment:
Drug: Lipid Regulating Drugs
Drug: Anti-Platelet Drugs
Drug: Coronary Vasodilator
Drug: Shuanghe Decoction
Qi stagnation and blood stasis
Experimental group
Description:
Patients in this group will be treated by Xuefu Zhuyu Decoction at the base of conventional western medicine.
Treatment:
Drug: Xuefu Zhuyu Decoction
Drug: Lipid Regulating Drugs
Drug: Anti-Platelet Drugs
Drug: Coronary Vasodilator
Phlegm and blood stasis
Experimental group
Description:
Patients in this group will be treated by Gualou Xiebai Banxia Decoction \& Danshen Decoction at the base of conventional western medicine.
Treatment:
Drug: Lipid Regulating Drugs
Drug: Anti-Platelet Drugs
Drug: Coronary Vasodilator
Drug: Gualou Xiebai Banxia Decoction & Danshen Decoction

Trial contacts and locations

0

Loading...

Central trial contact

Panpan Tian

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems